Shopping Cart
- Remove All
- Your shopping cart is currently empty
Citatuzumab bogatox (VB6-845) is a recombinant immunotoxin composed of a humanized antibody's Fab fragment targeting EpCAM and a modified bouganin cytotoxin. It selectively binds to EpCAM-positive cell lines, induces apoptosis, and demonstrates efficacy in EpCAM-positive human tumor xenograft models [1] [2] [3].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Citatuzumab bogatox (VB6-845) is a recombinant immunotoxin composed of a humanized antibody's Fab fragment targeting EpCAM and a modified bouganin cytotoxin. It selectively binds to EpCAM-positive cell lines, induces apoptosis, and demonstrates efficacy in EpCAM-positive human tumor xenograft models [1] [2] [3]. |
Cas No. | 945228-49-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.